Acadia Healthcare Company Inc (ACHC)

Return on assets (ROA)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands -21,667 -18,272 270,537 278,317 273,139 282,293 277,320 241,755 190,635 -663,315 -692,443 -695,878 -672,132 100,286 105,854 112,915 108,923 -211,460 -207,794 -197,098
Total assets US$ in thousands 5,358,840 5,346,220 5,150,210 5,044,260 4,987,900 4,943,100 4,882,640 4,834,640 4,768,080 4,594,730 4,564,000 4,526,920 6,499,360 7,105,140 6,833,230 6,718,000 6,879,140 6,728,120 6,790,420 6,785,520
ROA -0.40% -0.34% 5.25% 5.52% 5.48% 5.71% 5.68% 5.00% 4.00% -14.44% -15.17% -15.37% -10.34% 1.41% 1.55% 1.68% 1.58% -3.14% -3.06% -2.90%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $-21,667K ÷ $5,358,840K
= -0.40%

Acadia Healthcare Company Inc's return on assets (ROA) has exhibited some fluctuations over the past eight quarters. In Q4 2023, the ROA was at -0.40%, indicating a decrease from the previous quarter's -0.34%. This negative ROA suggests that the company generated a net loss relative to its total assets in this period.

In contrast, the ROA saw a significant improvement in Q2 2023, reaching 5.25%, followed by a slight decrease to 5.52% in Q1 2023. These positive ROAs reflect the company's efficiency in utilizing its assets to generate profits during these quarters.

Comparing the most recent ROA values to the same quarters in the previous year, Acadia Healthcare Company Inc's performance appears to have declined slightly. The ROA in Q4 2023 was lower than the ROA in Q4 2022, indicating a potential decrease in profitability relative to the total assets employed.

Overall, the fluctuations in Acadia Healthcare Company Inc's ROA suggest varying levels of profitability and asset utilization efficiency over the analyzed quarters. It would be important to further investigate the factors contributing to the negative ROAs and the potential impact on the company's overall financial performance and strategic direction.